undamentalytics Newsletter

Willis Towers Watson income statement

In fiscal 2025, Willis Towers Watson reported revenue of $9.71bn, down 2.2% on the year before, operating income of $2.23bn (a 23.0% margin) and net income of $1.60bn, or $16.26 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Willis Towers Watson: income statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3.33.33.43.53.73.83.87.98.28.58.48.69.08.99.59.99.710.3
Operating income0.70.80.6−0.20.70.60.40.30.50.81.10.92.21.21.40.62.22.3
Interest expense0.20.20.20.10.10.10.10.20.20.20.20.20.20.20.20.30.30.3
Income before tax0.50.60.2−0.30.50.50.30.30.50.91.01.02.71.31.30.12.02.0
Income tax0.10.10.00.10.10.2−0.0−0.1−0.10.10.20.20.50.20.20.20.30.4
Net income0.40.50.2−0.40.40.40.40.40.60.71.01.04.21.01.1−0.11.61.6
Diluted EPS$3.43$3.52$1.54−$3.42$2.69$2.66$2.71$3.04$4.18$5.27$8.02$7.65$32.78$8.98$9.95−$0.96$16.26$16.42
Diluted shares (average)128m129m133m131m136m136m138m138m136m132m130m130m129m112m106m102m99m95m
EBITDA0.90.90.7−0.30.80.80.60.50.81.01.31.22.51.41.60.92.52.5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BRO vs WTWAJG vs WTWAON vs WTWMRSH vs WTW

More: Insurance Brokers stocks compared, Financials sector, rankings of US companies

Figures from Willis Towers Watson's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Willis Towers Watson.